Actively Recruiting
The Assessment of Infrared Treatment for Crohn's Disease
Led by Shmuel Kivity, MD · Updated on 2026-02-24
40
Participants Needed
1
Research Sites
224 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to test the safety and efficacy of far Infra-red (fIR) therapy in Crohn's disease patients. The main questions it aims to answer are: 1. Is infrared therapy safe for treating Crohn's disease patients? 2. Is infrared therapy effective for treating Crohn's disease? Participants will be asked to attend 10 treatments of fIR therapy, provide stool and blood samples and answer questionnaires. Researchers will compare between 4 treatments: three intensities of fIR therapy and placebo treatment to explore which intensity is most effective for treating Crohn's disease.
CONDITIONS
Official Title
The Assessment of Infrared Treatment for Crohn's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Crohn's disease
- Age between 18 and 80 years
- Either not receiving therapy or on a stable medication regimen throughout the study: mesalamine for at least 6 weeks, steroids for at least 2 weeks, immunomodulatory drugs for at least 12 weeks, biologics for at least 12 weeks, or medical cannabis for at least 2 weeks before the study
- Symptoms score greater than 4 on the Harvey-Bradshaw index or fecal calprotectin level over 150 ug/gr
You will not qualify if you...
- Body mass index (BMI) greater than 30 kg/m2
- Current infections such as Clostridioides difficile infection, positive stool culture, or parasites
- Unable to sign informed consent or complete the study protocol
- Pregnancy
- Chronic conditions including cancer, organ transplant, advanced kidney or liver disease, or systemic inflammatory conditions other than inflammatory bowel disease
- Presence of abscesses or cysts in the liver, kidneys, or pancreas
- Evidence of abdominal abscess or entero-enteric fistula
- More than one Crohn's disease luminal surgery or small bowel length less than 1.5 meters
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Actively Recruiting
Research Team
N
Nitsan Maharshak, Professor
CONTACT
R
Rony Izhar, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here